Immunotherapy
Research News and Information

Monday, November 23, 2009

Subcutaneous anti-D treatment of idiopathic thrombocytopenic purpura in children.

13 Dec 2009 We investigated the effect of subcutaneous anti-D IgG as platelet enhancing therapy in children with idiopathic thrombocytopenic purpura (ITP). Twenty-three children were treated with subcutaneous anti-D 50 microg/kg. The median platelet count ... Read more...

Peptide inhibitors of transforming growth factor-beta enhance the efficacy of antitumor immunotherapy.

29 Nov 2009 Transforming growth factor-beta (TGF-beta) is a cytokine with potent immunosuppressive effects and is overexpressed in many tumors. Therefore, development of molecules able to inhibit TGF-beta is of paramount importance to improve the efficacy of ... Read more...

Immunotherapy for neuroblastoma: turning promise into reality.

29 Nov 2009 Neuroblastoma is one of the commonest and most aggressive paediatric malignancies. The majority of children present with metastatic disease for which long-term survival remains poor despite intensive multi-modal therapies. Toxicity from current ... Read more...

Latest indexed articles for 'Immunotherapy'

These are the very latest articles for this heading:

• Subcutaneous anti-D treatment of idiopathic thrombocytopenic purpura in children. 13 Dec 2009
• Peptide inhibitors of transforming growth factor-beta enhance the efficacy of antitumor immunotherapy. 29 Nov 2009
• Immunotherapy for neuroblastoma: turning promise into reality. 29 Nov 2009
• EUROGIN 2008 roadmap on cervical cancer prevention. 13 Nov 2009
• Immune responses in patients with metastatic renal cell carcinoma treated with dendritic cells pulsed with tumor lysate. 30 Oct 2009
• Controlling hepatitis C with immunotherapy. 30 Oct 2009
• The effects of electroacupuncture on TH1/TH2 cytokine mRNA expression and mitogen-activated protein kinase signaling pathways in the splenic T cells of traumatized rats. 30 Oct 2009
• Re: Practice parameters and technology assessments: what they are, what they are not, and why you should care. 18 Oct 2009
• "MIATA"-minimal information about T cell assays. 14 Oct 2009
• In vivo expansion of activated naive CD8+ T cells and NK cells driven by complexes of IL-2 and anti-IL-2 monoclonal antibody as novel approach of cancer immunotherapy. 13 Oct 2009
• Antibodies blocking adhesion and matrix binding domains of laminin-332 inhibit tumor growth and metastasis in vivo. 13 Oct 2009
• [Allergy vaccination] 3 Oct 2009
• Tau-focused immunotherapy for Alzheimer's disease and related tauopathies. 29 Sep 2009
• Adaptive immunity in hepatocellular carcinoma: prognostic and therapeutic implications. 29 Sep 2009
• Dermatomyositis-like muscle pathology in patients with chronic graft-versus-host disease. 29 Sep 2009
• EGFRvIII-targeted vaccination therapy of malignant glioma. 29 Sep 2009
• Dendritic cell therapy of high-grade gliomas. 29 Sep 2009
• Immunotherapy of diffuse gliomas: biological background, current status and future developments. 29 Sep 2009
• Immunotherapy of diffuse gliomas: helping the brain fight back! 29 Sep 2009
• Immunotherapy for multiple sclerosis: the curious case of interferon beta. 29 Sep 2009

See a longer list of these articles.

Technical information about 'Immunotherapy'

Definition: Manipulation of the host's immune system in treatment of disease. It includes both active and passive immunization as well as immunosuppressive therapy to prevent graft rejection.

Descriptor UI: D007167

Alternative terms: Immunotherapy; Immunotherapies;

Allowable Qualifiers: adverse effects; classification; economics; history; instrumentation; methods; mortality; nursing; psychology; standards; trends; utilization; veterinary; statistics & numerical data; contraindications; ethics; legislation & jurisprudence;

Tree Number: E02.095.520;

Online Note: use IMMUNOTHERAPY to search VACCINE THERAPY 1966-72

History Note: 73; VACCINE THERAPY was heading 1963-82

Technical Notes: GEN only; do not use /util except by MeSH definition; for ther: coord IM with dis /ther (IM)